Distinct pathophysiological mechanisms of Heterometrus laoticus and Lychas mucronatus scorpion venoms on cardiovascular and renal functions

Posted by
  Distinct pathophysiological mechanisms of Heterometrus laoticus and Lychas mucronatus scorpion venoms on cardiovascular and renal functions Abstract Background:    Heterometrus laoticus and Lychas mucronatus are widely distributed in Southeast Asia, yet their pathophysiological effects of both venoms remain poorly characterized due to low human fatality rates. This study compared their venom compositions and acute cardiovascular and renal effects. Methods:   Anesthetized male New Zealand White rabbits were monitored for blood pressure (BP), heart rate (HR), and renal clearance following intravenous administration of crude venom (0.5 mg/kg). Venom components were identified via LC-MS/MS, and hematological/biochemical parameters were assessed. Results:    H. laoticus venom induced a rapid, transient hypotension ( p < 0.05), followed by a mild, prolonged hypotensive phase (up to 120 min). Conversely, L. mucronatus venom elicited a biphasic response: ...

Snake Venom Meets Oncology: Unraveling the Anticancer Potential of Crotamine

Posted by

 

By Leandro Avelar - Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=49733700

Snake Venom Meets Oncology: Unraveling the Anticancer Potential of Crotamine

Abstract

Cancer remains a significant global health challenge, prompting the search for novel therapeutic strategies that minimize the limitations of current treatments. Crotamine, a cationic myotoxin isolated from the venom of Crotalus durissus spp., has emerged as a promising anticancer candidate due to its selective cytotoxicity toward tumor cells and multifaceted biological activities. This review examines the structural and functional characteristics of crotamine, emphasizing its mechanisms of action, such as disruption of ionic homeostasis through calcium influx, inhibition of voltage-gated potassium channels (Kv), and its preferential uptake by proliferating cells as a cell-penetrating peptide (CPP). Moreover, crotamine facilitates the intracellular delivery of bioactive compounds, enhancing drug selectivity and efficacy. Preclinical studies have demonstrated its ability to inhibit tumor growth both in vitro and in vivo, with minimal toxicity to normal tissues and low immunogenicity. These features position crotamine as a strong candidate for anticancer drug development. However, further investigation is essential to fully elucidate its molecular targets and mechanisms and to support its clinical translation.
Jacob, B., Alberghini-dos-Santos, J., Ferreira, I., Vieira, B., Malachias-Pires, G., Cerni, F., Pucca, M., Arantes, E., & Oliveira, I. (2025). Snake Venom Meets Oncology: Unraveling the Anticancer Potential of Crotamine. Toxicon, 108670. https://doi.org/10.1016/j.toxicon.2025.108670